AI assistant
Sending…
Ocugen, Inc. — Director's Dealing 2019
Nov 21, 2019
32915_dirs_2019-11-20_43a658a0-21ff-4035-ad64-edfea10f16ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2019-11-18
Reporting Person: Zhang Junge (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-18 | Common Stock | P | 100000 | $.41 | Acquired | 135078 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 212863 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.41 to $0.42. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4.
More from Ocugen, Inc.
Board/Management Information
2026
Jun 3
Board/Management Information
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Capital/Financing Update
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Capital/Financing Update
2026
Mar 20
Annual Report
2026
Mar 4